James Malcolm Heather, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Antigen, T-Cell | 8 | 2022 | 2568 | 1.270 |
Why?
|
High-Throughput Nucleotide Sequencing | 9 | 2021 | 3665 | 0.710 |
Why?
|
Phosphopeptides | 1 | 2019 | 240 | 0.620 |
Why?
|
Sequence Analysis, DNA | 4 | 2018 | 4780 | 0.580 |
Why?
|
Software | 5 | 2022 | 4463 | 0.480 |
Why?
|
HLA Antigens | 1 | 2019 | 1338 | 0.460 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 5 | 2020 | 808 | 0.370 |
Why?
|
T-Lymphocytes | 7 | 2021 | 10273 | 0.290 |
Why?
|
Complementarity Determining Regions | 2 | 2018 | 150 | 0.280 |
Why?
|
Common Variable Immunodeficiency | 2 | 2019 | 100 | 0.280 |
Why?
|
Proteomics | 1 | 2019 | 3901 | 0.260 |
Why?
|
Immunoconjugates | 2 | 2022 | 968 | 0.210 |
Why?
|
Genes, Immunoglobulin | 1 | 2024 | 286 | 0.210 |
Why?
|
Genetic Variation | 1 | 2018 | 6610 | 0.210 |
Why?
|
Lymphopenia | 1 | 2024 | 290 | 0.200 |
Why?
|
DNA, Complementary | 2 | 2022 | 1992 | 0.180 |
Why?
|
Immunoglobulins | 1 | 2024 | 856 | 0.180 |
Why?
|
HIV Long-Term Survivors | 1 | 2021 | 140 | 0.170 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2019 | 89 | 0.170 |
Why?
|
Cytomegalovirus | 2 | 2022 | 755 | 0.160 |
Why?
|
Antibody Diversity | 1 | 2018 | 72 | 0.160 |
Why?
|
Cholangiocarcinoma | 1 | 2024 | 563 | 0.150 |
Why?
|
Bile Duct Neoplasms | 1 | 2024 | 617 | 0.150 |
Why?
|
Immunologic Memory | 3 | 2020 | 1375 | 0.150 |
Why?
|
Antigens | 2 | 2020 | 1443 | 0.140 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2019 | 452 | 0.140 |
Why?
|
Chromosomes, Human, X | 1 | 2019 | 321 | 0.140 |
Why?
|
Immunoglobulin Variable Region | 1 | 2018 | 420 | 0.140 |
Why?
|
X Chromosome Inactivation | 1 | 2019 | 229 | 0.140 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 1104 | 0.130 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2020 | 828 | 0.130 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2018 | 305 | 0.130 |
Why?
|
Lymphocyte Activation | 3 | 2021 | 5495 | 0.120 |
Why?
|
Antibodies | 2 | 2022 | 2425 | 0.120 |
Why?
|
Cytomegalovirus Infections | 1 | 2022 | 839 | 0.120 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1839 | 0.120 |
Why?
|
Mice, SCID | 1 | 2019 | 2633 | 0.120 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2015 | 134 | 0.120 |
Why?
|
Antigen Presentation | 1 | 2019 | 1251 | 0.110 |
Why?
|
Base Sequence | 2 | 2022 | 12428 | 0.110 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2017 | 549 | 0.110 |
Why?
|
Mass Spectrometry | 1 | 2019 | 2204 | 0.100 |
Why?
|
Transplantation, Heterologous | 1 | 2019 | 2393 | 0.090 |
Why?
|
Amino Acid Sequence | 1 | 2022 | 13452 | 0.090 |
Why?
|
Computational Biology | 3 | 2020 | 3546 | 0.090 |
Why?
|
Nanotechnology | 1 | 2015 | 714 | 0.090 |
Why?
|
Cell Nucleus | 1 | 2019 | 2889 | 0.090 |
Why?
|
Hematopoiesis | 1 | 2019 | 2058 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 4642 | 0.080 |
Why?
|
History, 21st Century | 1 | 2015 | 1575 | 0.080 |
Why?
|
Leukocytes | 1 | 2017 | 2030 | 0.080 |
Why?
|
Phosphorylation | 1 | 2019 | 8332 | 0.080 |
Why?
|
Cell Line | 2 | 2019 | 15609 | 0.070 |
Why?
|
History, 20th Century | 1 | 2015 | 2772 | 0.070 |
Why?
|
Mice, Knockout | 2 | 2019 | 14480 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2022 | 20231 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 6091 | 0.070 |
Why?
|
Algorithms | 4 | 2021 | 14158 | 0.060 |
Why?
|
DNA | 1 | 2019 | 7213 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4906 | 0.060 |
Why?
|
Anti-HIV Agents | 1 | 2021 | 4567 | 0.060 |
Why?
|
Humans | 20 | 2024 | 768451 | 0.050 |
Why?
|
Immunophenotyping | 2 | 2019 | 1869 | 0.050 |
Why?
|
Mice | 4 | 2022 | 82045 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5709 | 0.040 |
Why?
|
Neoplasms | 2 | 2020 | 22386 | 0.040 |
Why?
|
Germ Cells | 1 | 2024 | 641 | 0.040 |
Why?
|
Inflammation | 1 | 2019 | 10865 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2022 | 618 | 0.040 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9507 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2020 | 743 | 0.040 |
Why?
|
B-Lymphocyte Subsets | 1 | 2019 | 240 | 0.040 |
Why?
|
Endodeoxyribonucleases | 1 | 2019 | 166 | 0.040 |
Why?
|
Animals | 5 | 2022 | 169418 | 0.040 |
Why?
|
Matrix Metalloproteinases | 1 | 2020 | 394 | 0.040 |
Why?
|
Gene Library | 1 | 2020 | 1064 | 0.040 |
Why?
|
Receptors, Complement 3d | 1 | 2016 | 117 | 0.030 |
Why?
|
Viruses | 1 | 2020 | 373 | 0.030 |
Why?
|
Epitope Mapping | 1 | 2017 | 300 | 0.030 |
Why?
|
Immunomodulation | 1 | 2020 | 550 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2526 | 0.030 |
Why?
|
Organ Specificity | 1 | 2020 | 1972 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2019 | 613 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2020 | 736 | 0.030 |
Why?
|
Immunoglobulin Class Switching | 1 | 2016 | 289 | 0.030 |
Why?
|
Lymphocyte Depletion | 1 | 2016 | 605 | 0.030 |
Why?
|
HIV Infections | 1 | 2021 | 17564 | 0.030 |
Why?
|
Clone Cells | 1 | 2017 | 1672 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2019 | 19041 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2020 | 1362 | 0.030 |
Why?
|
Receptors, Androgen | 1 | 2019 | 1084 | 0.030 |
Why?
|
Autoantigens | 1 | 2017 | 894 | 0.030 |
Why?
|
Cell Count | 1 | 2017 | 1835 | 0.030 |
Why?
|
Alleles | 1 | 2024 | 6890 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2021 | 22293 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2020 | 1814 | 0.020 |
Why?
|
Thymus Gland | 1 | 2016 | 1267 | 0.020 |
Why?
|
DNA Primers | 1 | 2015 | 2826 | 0.020 |
Why?
|
Amino Acids | 1 | 2017 | 1714 | 0.020 |
Why?
|
Zebrafish | 1 | 2022 | 3038 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2017 | 1750 | 0.020 |
Why?
|
Survival Rate | 1 | 2024 | 12875 | 0.020 |
Why?
|
Peptides | 1 | 2022 | 4368 | 0.020 |
Why?
|
Immunotherapy, Adoptive | 1 | 2020 | 1505 | 0.020 |
Why?
|
Autoimmunity | 1 | 2017 | 1361 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2017 | 2358 | 0.020 |
Why?
|
Middle Aged | 4 | 2024 | 223418 | 0.020 |
Why?
|
Graft vs Host Disease | 1 | 2018 | 3042 | 0.020 |
Why?
|
Homeostasis | 1 | 2017 | 3351 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5904 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2017 | 2531 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2017 | 3472 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4421 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2017 | 4419 | 0.010 |
Why?
|
Models, Biological | 1 | 2020 | 9505 | 0.010 |
Why?
|
Prognosis | 1 | 2024 | 30028 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 17149 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2021 | 65409 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2016 | 4781 | 0.010 |
Why?
|
Skin | 1 | 2017 | 4520 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16712 | 0.010 |
Why?
|
Female | 4 | 2024 | 396943 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2024 | 39430 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2019 | 11674 | 0.010 |
Why?
|
Melanoma | 1 | 2020 | 5740 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26351 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18478 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40271 | 0.010 |
Why?
|
Aged | 2 | 2024 | 171520 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2024 | 59680 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 11930 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22365 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2018 | 26395 | 0.010 |
Why?
|
Adult | 2 | 2024 | 223542 | 0.010 |
Why?
|
Infant | 1 | 2018 | 36497 | 0.010 |
Why?
|
Child, Preschool | 1 | 2018 | 42623 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2024 | 81834 | 0.010 |
Why?
|
Male | 2 | 2024 | 364781 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 60045 | 0.010 |
Why?
|
Child | 1 | 2018 | 80863 | 0.010 |
Why?
|